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Brucella melitensis is the etiological agent responsible for brucellosis. Present in
the B. melitensis genome is a 116-residue protein related to arsenate reductases
(Bm-YffB; BR0369). Arsenate reductases (ArsC) convert arsenate ion
(H2AsO4
 ), a compound that is toxic to bacteria, to arsenite ion (AsO2
 ), a
product that may be efﬁciently exported out of the cell. Consequently, Bm-YffB
is a potential drug target because if arsenate reduction is the protein’s major
biological function then disabling the cell’s ability to reduce arsenate would
make these cells more sensitive to the deleterious effects of arsenate. Size-
exclusion chromatography and NMR spectroscopy indicate that Bm-YffB is a
monomer in solution. The solution structure of Bm-YffB (PDB entry 2kok)
shows that the protein consists of two domains: a four-stranded mixed  -sheet
ﬂanked by two  -helices on one side and an  -helical bundle. The  /  domain is
characteristic of the fold of thioredoxin-like proteins and the overall structure is
generally similar to those of known arsenate reductases despite the marginal
sequence similarity. Chemical shift perturbation studies with
15N-labeled
Bm-YffB show that the protein binds reduced glutathione at a site adjacent
to a region similar to the HX3CX3R catalytic sequence motif that is important
for arsenic detoxiﬁcation activity in the classical arsenate-reductase family of
proteins. The latter observation supports the hypothesis that the ArsC-YffB
family of proteins may function as glutathione-dependent thiol reductases.
However, comparison of the structure of Bm-YffB with the structures of
proteins from the classical ArsC family suggest that the mechanism and possibly
the function of Bm-YffB and other related proteins (ArsC-YffB) may differ
from those of the ArsC family of proteins.
1. Introduction
Brucella melitensis is a facultative intracellular bacterial pathogen
that exhibits a host preference for goats and sheep. It is one of the
Brucella species identiﬁed as being responsible for brucellosis, a
zoonotic disease that causes abortions and stillbirths in animals and
Malta fever in humans. The disease is transmitted to humans
primarily via contact with infected animals (alive or dead) or the
consumption of unpasteurized dairy products (Young, 1995). In
undeveloped regions of the Mediterranean, Asia, Africa and Latin
America brucellosis infections are a major problem in livestock and
human populations, causing severe economic hardship (Corbel,
1997). In humans, the disease is multi-systemic and the symptoms are
nonspeciﬁc, including fever, chills, malaise, dementia, fatigue, head-
aches, nausea, vomiting and constipation. Infections can be success-
fully treated with antimicrobial agents that are able to penetrate well
into the host cells, often a combination of doxycycline and strepto-
mycin or doxycycline and rifampin for prolonged periods of time
(Young, 1995; Rubinstein et al., 1991). There is much interest in the
pathobiology of strains of Brucella because it is a potential agent of
biological warfare and its pathogenicity is unique in that the organism
does not display any obvious ‘classical’ virulence factors (Moreno &
Moriyon, 2002).
Arsenic, a naturally occurring metalloid element that is frequently
abundant in the environment (Messens & Silver, 2006), is a human
carcinogen (Shi et al., 2004) that is also toxic to most forms of life. The
toxic effects arise from the reactivity of arsenic ions with proteinthiols. To counter the toxic effects, a family of arsenic detoxiﬁcation
enzymes has evolved that convert arsenate ion (H2AsO4
 ), the highly
reactive form of arsenic, to arsenite ion (AsO2
 ), a compound that
may be effectively transported outside the cell (Mukhopadhyay et al.,
2002). In B. melitensis, YffB, a protein with marginal sequence
similarity to the classical family of arsenate reductases (ArsC), is
found that may play a role in reducing arsenate (DelVecchio et al.,
2002). This 13.5 kDa protein (Bm-YffB) is a potential drug target
because if arsenate reduction is this protein’s major biological func-
tion, contributing to the organism’s virulence, then disabling this
protein and the cell’s ability to reduce arsenate would make
B. melitensis more sensitive to the deleterious effects of endogenous
arsenate. Towards understanding the biological function of Bm-YffB
and providing a blueprint for structure-based drug design (Myler et
al., 2009) based on this protein, the solution structure ofBm-YffB was
determined. Its thermostability was measured by CD spectroscopy
and its structure was compared with those of a similar protein,
Pseudomonas aeruginosa YffB (Pa-YffB; PDB entry 1rw1; Teplyakov
et al., 2004), and a protein known to reduce arsenate, Escherichia coli
ArsC (Ec-ArsC; PDB entry 1id9; Martin et al., 2001).
2. Materials and methods
2.1. Cloning, expression and purification
The Bm-Yffb gene (BR0369; YP_4138591.1) was ampliﬁed using
the genomic DNA of B. melitensis biovar Abortus 2308 and the
oligonucleotide primers 50-GGGTCCTGGTTCGATGAGTGTGA-
CCATTTACGGCATC-30 (forward) and 50-CTTGTTCGTGCTG-
TTTATTATAGCTTAAAATAAGCTTCATACTGCG-30 (reverse)
(Invitrogen, Carlsbad, California, USA). The ampliﬁed Bm-YffB
gene was then gel-puriﬁed, treated with T4 DNA polymerase and
annealed into the NruI/PmeI-digested expression vector AVA0421
at a site that provided a 21-residue tag containing six consecutive
histidine residues (MAHHHHHHMGTLEAQTQGPGS-) at the
N-terminus of the expressed protein (Choi et al., 2011). The recom-
binant plasmid was transformed into E. coli BL21(DE3)R3-pRARE2
cells (a gift from SGC Toronto, Toronto, Ontario, Canada) using a
heat-shock method. Uniformly
15N- and
15N-,
13C-labeled Bm-YffB
was obtained by growing the transformed cells (310 K) in minimal
medium(Miller)containing
15NH4Cl(1 mg ml
 1)an dd-[
13C6]-glucose
(2.0 mg ml
 1) supplemented with FeCl3 (50 mgm l
 1) and the anti-
biotics chloramphenicol (35 mgm l
 1) and ampicillin (100 mgm l
 1).
Once the cells reached an OD600 of  0.8, the cells were cooled to
298 K and protein expression was induced with isopropyl  -d-1-
thiogalactopyranoside (0.026 mgm l
 1). After approximately 5 h, the
cells were harvested by mild centrifugation and frozen at 193 K. The
frozen pellet was later thawed and resuspended in  35 ml lysis buffer
(0.3 M NaCl, 50 mM sodium phosphate, 10 mM imidazole, pH 8.0)
brought to 0.2 mM phenylmethylsulfonyl ﬂuoride (PMSF) prior to
three passes through a French press (SLM Instruments, Rochester,
New York, USA). Following 60 s sonication (SLM Instruments,
Rochester, New York, USA) the cell debris was pelleted by centri-
fugation at 25 000g for 1 h in a JA-20 rotor (Beckman Instruments,
Fullerton, California, USA). The supernatant was then passed
through a 0.45 mm syringe ﬁlter and applied onto an Ni–NTA afﬁnity
column (Qiagen, Valencia, California, USA) containing  25 ml resin.
The column was washed stepwise by gravity with 40 ml buffer (0.3 M
NaCl, 50 ml sodium phosphate pH 8.0) containing increasing con-
centrations of imidazole (5, 10, 20, 50 and 250 mM). Bm-YffB eluted
primarily in the 250 mM imidazole wash. Following exchange into 3C
cleavage buffer by overnight dialysis in 4 l cleavage buffer (150 mM
NaCl, 20 mM Tris–HCl, pH 8.4) the protein was concentrated to
 2 ml (Amicon Centriprep-10) and the N-terminal polyhistidine tag
was removed by overnight incubation with 3C protease (1 mg per
50 mg target protein) at 279 K (Bryan et al., 2011). Using a ﬂow rate of
1.0 ml min
 1, the reaction solution was then loaded onto a Superdex
75 HiLoad 16/60 column (GE Healthcare, Piscataway, New Jersey,
USA) to simultaneously purify the protein and exchange it into NMR
buffer (100 mM NaCl, 20 mM Tris–HCl, 1.0 mM dithiothreitol, pH
7.1). The band containing Bm-YffB (retention time 78 min) was
collected and the volume was reduced (Amicon Centriprep-10) to
generate NMR samples in the 1–2 mM range (Lowry analysis). SDS–
PAGE analysis of the ﬁnal NMR samples showed the protein to be
greater than  95% pure.
2.2. Circular dichroism spectroscopy
An Aviv Model 410 spectropolarimeter (Lakewood, New Jersey,
USA) calibrated with an aqueous solution of ammonium d-(+)-
camphorsulfonate was used to collect circular dichroism data from a
0.05 mMB m -YffB sample in NMR buffer in a quartz cell of 0.1 cm
path length. A thermal denaturation curve was obtained by recording
the ellipticity at 216 nm in 2.0 K intervals from 283 to 353 K. A
quantitative estimation of the melting temperature, Tm, was obtained
by taking a ﬁrst derivative of the thermal denaturation curve using
the Aviv software (Greenﬁeld, 2006). Steady-state wavelength
spectra for Bm-YffB were recorded in 0.5 nm increments between
200 and 260 nm at 298 and 353 K. Each reported steady-state
wavelength spectrum was the result of averaging two consecutive
scans with a bandwidth of 1.0 nm and a time constant of 1.0 s. These
spectra were processed by subtracting a blank spectrum from the
protein spectrum and then automatically line-smoothing the data
using the Aviv software.
2.3. Nuclear magnetic resonance spectroscopy
Varian 800-, 750- and 600-Inova spectrometers equipped with
1H/
13C/
15N triple-resonance probes and pulse-ﬁeld gradients were
used to collect the NMR data required for resonance assignments and
structure determination. The NMR data, which were collected from
1–2 mM samples at 293 K, were processed with Felix2007 (Felix
NMR Inc., San Diego, California, USA) and analyzed with Sparky
(v.3.115; Goddard & Kneller, 2008). Assignments of the
1H,
13C and
15N chemical shifts for the backbone and side-chain resonances were
made from standard 2D
1H–
15N HSQC,
1H–
13C HSQC, HBCBC-
GCDHD and HBCBCGCDCHE experiments and 3D HNCACB,
CBCA(CO)NH, HNCO, HCC-TOCSY-NNH and CC-TOCSY-NNH
experiments using Varian Protein Pack pulse programs. Chemical
shifts were referenced to DSS (DSS = 0 p.p.m.) using indirect
methods (Wishart et al., 1995). Distance restraints were obtained
from a suite of 3D
13C- and
15N-edited NOESY-HSQC experiments
using a mixing time of 80 ms. Deuterium-exchange studies were
performed by lyophilizing a
15N-labeled NMR sample, re-dissolving it
in 99.8% D2O and immediately collecting
1H–
15N HSQC spectra 10,
20 and 60 min after exchange. An overall rotational correlation time,
tc, was estimated from backbone-amide
15N T1/T1  ratios (Farrow et
al., 1994; Buchko et al., 2008). A chemical shift perturbation experi-
ment was performed by adding aliquots of reduced glutathione in
NMR buffer (50 mM)t oa0 . 5m M sample of
15N-labeled Bm-YffB.
Following gentle agitation,
1H–
15N HSQC spectra were collected at
glutathione:Bm-YffB molar ratios of 0.3:1, 0.6:1, 1:1 and 2:1.
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The chemical shifts for Bm-YffB were assigned using conventional
methods (Cavanagh et al., 1996) and were deposited in the Biological
Magnetic Resonance Data Bank (BMRB) under accession No. 16517.
Using these
1H,
13C and
15N chemical shift assignments and the peak-
picked data from
13C- and
15N-edited NOESY-HSQC experiments as
initial inputs, structure calculations were performed iteratively using
CYANA (v.2.1; Gu ¨ntert, 2004). 184 dihedral angle restraints for both
’ and   were introduced on the basis of the elements of secondary
structure identiﬁed in the early structural ensembles and TALOS
calculations (Cornilescu et al., 1999). Near the end of the iterative
process, 84 hydrogen-bond restraints (1.8–2.0 and 2.7–3.0 A ˚ for the
NH—O and N—O distances, respectively) were introduced into the
structure calculations on the basis of proximity in early structure
calculations and the observation of slowly exchanging amides in the
deuterium-exchange experiment. On the basis of the chemical shift
difference between the proline
13C
  and
13C
  atoms (Schubert et al.,
2002), Pro93 was placed in the cis conformation. From the ﬁnal set of
100 calculated structures, the 20 with the lowest target function were
selected and this ensemble was deposited in the Protein Data Bank
(PDB) under PDB code 2kok. Structural quality was assessed using
the Protein Structure Validation Suite (PSVS; v.1.3; Bhattacharya et
al., 2007). Note that the deposited structures were not reﬁned with
explicit water (Linge et al., 2003) because these calculations con-
tinuously introduced unfavorable steric clashes into the structures
despite numerous attempts to adjust the parameters. A summary of
the structure statistics is provided in Table 1.
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Table 1
Summary of the structural statistics for Bm-YffB.
All statistics are for the 20-structure ensemble deposited in the PDB (2kok).
Restraints for structure calculations
Total NOEs 1490
Intraresidue NOEs 436
Sequential (i, i + 1) NOEs 449
Medium-range (i, i + j;1<j   4) NOEs 282
Long-range (i, i + j; j > 4) NOEs 323
’-angle restraints 94
 -angle restraints 94
Hydrogen-bond restraints 84
Structure calculations
No. of structures calculated 100
No. of structures used in ensemble 20
Structures with restraint violations
Distance restraint violations > 0.05 A ˚ 0
Dihedral restraint violations > 2  0
R.m.s.d. from mean† (A ˚ )
Backbone N—C
 —C O atoms 0.69   0.16
Heavy atoms 1.19   0.11
Ramachandran plot summary for selected residues (from PROCHECK)‡
Most favored regions (%) 89.8
Additionally allowed regions (%) 10.2
Generously favored regions (%) 0.0
Disallowed regions (%) 0.0
Global quality scores for ordered residues‡§
PROCHECK (all)  2.84 ( 0.48)
PROCHECK (’,  )  0.28 ( 0.15)
MolProbity clash score  0.86 (13.91)
† Calculated for the ordered residues Val3–Ile8, Cys11–Ala59, Thr61–Asp98 and
Lys100–Lys115. ‡ Calculated for the central ordered core, Ser2–Ile8 and Cys11–
Lys115, using PSVS.§ Z scores; values in parentheses are raw values.
Figure 1
Assigned
1H–
15N HSQC spectrum of double-labeled Bm-YffB collected at 293 K
in NMR buffer (100 mM NaCl, 20 mM Tris–HCl, 1.0 mM DTT, pH 7.1) at a
1H
resonance frequency of 750 MHz. Side-chain –NH2 resonances are indicated by
dashed horizontal lines (red) and the exchangeable ring resonances for Trp20 and
Trp53 are identiﬁed with an ‘r’.
Figure 2
(a) Superposition of the cartoon representations of the ensemble of structures calculated for Bm-YffB (PDB entry 2kok), with  -helices colored blue and  -strands colored
gold. (b) Cartoon representation of the structure most similar to the average structure of the ensemble, with the four  -strands and seven  -helices labeled.The amino-acid sequence of Bm-YffB deposited in the PDB and
BMRB is numbered sequentially, Gly1–Leu120, starting with the
four non-native residues (GPGS-) that remained after 3C protease
treatment. However, here the ﬁrst four non-native residues are
numbered sequentially with asterisks (Gly1*–Ser4*) and the ﬁrst
native residue, Met5 in the PDB and BMRB depositions, is labeled
Met1.
3. Results and discussion
3.1. Solution structure of Bm-ArsC
The elution time of Bm-YffB on a Superdex 75 HiLoad 16/60
column was within a range consistent with a monomeric  14 kDa
protein (data not shown). Such a conclusion was corroborated by the
experimentally estimated rotational correlation time determined for
Bm-YffB, 9.1   0.2 ns (293 K), a value that is more consistent with a
monomeric  14 kDa protein than an  28 kDa dimer (Bhattacharjya
et al., 2004). The line widths and chemical shift dispersion of the
1H–
15N HSQC spectrum for Bm-YffB, shown in Fig. 1, were also
characteristic of a folded monomeric protein with a molecular weight
in the 15 kDa range. As illustrated in Fig. 1, 121 of the expected 123
amide resonances for Bm-YffB [120   (6 prolines + Gly1*)] were
assigned in the
1H–
15N HSQC spectrum. Amide cross-peaks for
Asp16 and Phe109 were not unambiguously identiﬁed. On the basis
of these amide assignments and extensive assignment of the
13C
  and
side-chain proton and carbon chemical shifts (BMRB ID 16517), an
ensemble of structures was calculated (Fig. 2a) that satisﬁed all of the
available experimental NMR data(NOEs, chemical shifts, deuterium-
exchange experiments and TALOS calculations).
As summarized in Table 1, a total of 1490 interproton distance
restraints, 84 hydrogen-bond restraints and 188 dihedral angle
restraints were used in the ﬁnal structure calculations. Each member
of the ﬁnal ensemble of 20 calculated structures agreed well with the
experimental data, with no upper limit violation of greater than
0.05 A ˚ and no torsion-angle violation of greater than 2 . Analysis of
the ensemble with the PSVS validation-software package (Bhatta-
charya et al., 2007) also showed that the quality of the structures in
the ﬁnal ensemble was good. The Ramachandran statistics for all
residues in the ensemble were overwhelmingly in acceptable space
[90% of the (’,  ) pairs for Bm-YffB were found in the most favored
regions and 10% were within additionally allowed regions] and all the
structure-quality Z scores were acceptable (> 5).
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Figure 3
Stereoview showing a cartoon representation of the structure most similar to the
average structure in the ensemble, with the protein rainbow-colored (ROYGBIV)
from the N-terminus to the C-terminus.
Table 2
Chemical shift difference between the proline
13C
  and
13C
  atoms in Bm-YffB.
Residue    (p.p.m.)
Pro2* 5.0
Pro51 5.0
Pro67 4.6
Pro87 4.2
Pro93 8.7
Pro107 4.2
Average for trans-Pro 4.51   1.17†
Average for cis-Pro 9.64   1.27†
† Average values obtained from Schubert et al. (2002).
Figure 4
Maps generated using PyMOL (DeLano, 2002) of the electrostatic potential at the
solvent-accessible surface of Bm-YffB. The long axis of the protein is illustrated
and is sequentially rotated 90  about the horizontal axis four times.The ﬁnal set of 20 calculated structures in the ensemble converge
well, as shown mathematically by the statistics in Table 1 and visually
by the superposition in Fig. 2(a). The r.m.s.d.s of the structured core
regions (Val3–Ile8, Cys11–Ala59, Thr61–Asp98 and Lys100–Lys115)
in the ensemble from the mean structure are 0.7 A ˚ for the backbone
atoms (N—C
 —C O) and 1.2 A ˚ for all heavy atoms. Fig. 2(b)
illustrates the single structure in the ensemble that is nearest to the
mean structure and Fig. 3 shows a stereoview of this single structure.
The protein consists of two domains: a four-stranded mixed  -sheet
ﬂanked by two  -helices on one face and an  -helical bundle. The  / 
domain is composed of a  4– 3– 1– 2  -sheet, with  4– 3– 1
aligned antiparallel and  1– 2 aligned parallel.  -Helix 1 (Asp12–
His24) is tucked in behind  1– 2, and  7 (Pro107–Phe114) is tucked
in behind  4– 3. The  /  domain is characteristic of the fold of
thioredoxin-like proteins and usually contains a cis-proline on the
N-terminal side of  3 that plays a role in theintegrity ofthe active site
(Martin, 1995). Bm-YffB also contains a proline, Pro93, at this
position and analysis of the
13C
  and
13C
  chemical shifts for this
residue indicates that it is also in the cis conformation (Table 2;
Schubert et al., 2002). The other domain in Bm-YffB is an  -helical
bundle dominated by  3 (Ala40–Thr49) and  6 (Ala76–Ala85), with
three short helices [ 2 (Tyr33–Glu36),  4 (Thr61–Lys65) and  5
(Glu68–Ser72)] around them. Hydrophobic interactions between the
side chains of residues on the interface of these two domains,
including Phe46 ( 3), Thr49 ( 3), Tyr6 ( 1) and Leu101 ( 4), assist in
holding the domains together. As shown in Fig. 4, the protein con-
tains a polarized distribution of charges on its surface, with a domi-
nance of positive surfaces. Such a distribution of charges has been
observed in the ArsC protein family, as well as for Pa-YffB, and
would favor the binding of anions such as arsenate (Teplyakov et al.,
2004).
3.2. Circular dichroism profile and thermal stability of Bm-ArsC
Circular dichroism (CD) spectroscopy is very sensitive to changes
in a protein’s backbone and, consequently, is a powerful tool to
rapidly probe the conformation of proteins in solution and to assess
the effect of variables such as pH, salt content and temperature on
the structure of a protein (Woody, 1974). Fig. 5(a) shows the steady-
state CD spectrum of Bm-YffB collected at 298 K. The dominant
feature of the spectrum is characteristic of  -helical secondary
structure: a double minimum at approximately 220 and 208 nm and
an extrapolated maximum around 195 nm (Holzwarth & Doty, 1965;
Greenﬁeld, 2006). Such an observation is expected given the amount
of helical structure (46%) observed in the solution structure of the
protein (Figs. 2 and 3). Note that the double minimum is skewed and
is more intense around 220 nm, which is likely to be due to the
contributions of other elements of secondary structure to the CD
steady-state spectrum.
By monitoring the increase in the ellipticity at a speciﬁc wave-
length with increasing temperature, the thermal stability of a protein
may be measured and a melting temperature (Tm) estimated for the
transition between a structured and an unstructured state (Karant-
zeni et al., 2003). As shown in Fig. 5(b), a gradual increase in ellip-
ticity at 220 nm is observed for Bm-YffB up to  323 K, followed by a
more rapid increase in ellipticity that tails off and plateaus at  333 K.
Visual inspection of the sample after heating to 353 K showed
evidence of precipitation, indicating that the unfolding was irrever-
sible and that the CD data may not be analyzed thermodynamically
(Karantzeni et al., 2003). However, a quantitative estimation of the
Tm for this transition may still be obtained by assuming a two-state
model and taking a ﬁrst derivative of the curve shown in Fig. 5(b)
(Greenﬁeld, 2006). The maximum of this ﬁrst derivative, shown in
Fig. 5(c), is 326.6 K.
3.3. Comparison with related structures
The PDB was searched for structures similar to Bm-YffB using the
DALI search engine (Holm & Rosenstro ¨m, 2010). The search indi-
cated that the structure of Bm-YffB was most similar (Z score = 13.4)
to that of the conserved hypothetical protein YffB from P. aeruginosa
(PDB entry 1rw1; Teplyakov et al., 2004). This similarity is evident
in Fig. 6, which shows a superposition of the two structures with the
program SuperPose (Maiti et al., 2004). It is evident that both proteins
have the same number of  -strands and  -helices organized into a
similar two-domain structure. Indeed, using Bm-YffB residues Ser2–
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Figure 5
(a) Circular dichroism steady-state wavelength spectrum for Bm-YffB (0.05 mM) in NMR buffer collected at 298 K. (b) The CD thermal melt for Bm-YffB obtained by
measuring the ellipticity at 216 nm in 2.0 K intervals between 283 and 353 K. (c) The ﬁrst derivative of the thermal melt curve shows that the protein has a melting
temperature of 326.6 K.Lys115 the backbone r.m.s.d. is 3.78 A ˚ between Bm-YffB and the
equivalent region in Pa-YffB. Such similarity between the structures
of the two proteins is reasonable given that the amino-acid sequences
of the two proteins are 56% identical and 70% similar.
After Pa-YffB, the DALI search identiﬁed a number of proteins
with Z scores between 11.3 and 10.0 that were annotated as arsenate
reductases (ArsC) or Spx regulatory proteins. While the structure of
Bm-YffB produced high DALI Z scores with these two types of
proteins, the sequence identity between Bm-YffB and these proteins
was only 14–27%. The Spx protein is a global transcription regulatory
protein that does not bind DNA as part of its regulatory role but
instead binds to the  -subunit of RNA polymerase to control gene
expression in response to disulﬁde-stress conditions (Nakano et al.,
2005). In Spx it is hypothesized that disulﬁde-bond formation in a
CXXC motif triggers events that result in an increase in the cellular
levels of thioredoxin and thioredoxin reductase (Nakano et al., 2003).
Because Bm-YffB is a monomer and contains only a single cysteine
residue, it is unlikely that it functions as a regulatory protein using a
mechanism similar to that which may be employed by Spx. On the
other hand, Bm-YffB contains a sequence that is somewhat similar to
the HX3CX3R catalytic sequence motif that is important for arsenic
detoxiﬁcation activity in the arsenate-reductase family of proteins
(ArsC; Martin et al., 2001); hence, it is more likely that Bm-YffB has a
function related to arsenate reduction.
Fig. 7 shows a superposition of a representative structure of
Bm-YffB (PDB entry 2kok) with the crystal structure of E. coli ArsC
(Ec-ArsC) in the native form (PDB entry 1id9; Martin et al., 2001)
using the program SuperPose (Maiti et al., 2004). Apart from an extra
two-stranded  -sheet at the C-terminus of Ec-ArsC, the two struc-
tures are generally similar to each other: a four-stranded mixed
 -sheet is ﬂanked by a number of  -helices that generate a similar
overall fold. One major difference between the two structures,
highlighted in Fig. 7, is the presence of a triad of arginine residues,
Arg60, Arg94 and Arg106 (red), in Ec-ArsC that is absent in
Bm-YffB. These three arginines have been reported to be essential
for enzymatic function, forming a thiasahydroxyl adduct when bound
to arsenate (Martin et al., 2001). In the Bm-YffB structure only one
arginine, Arg96 (black), is found in this area. Such a major structural
difference suggests a difference in substrate speciﬁcity between Bm-
YffB and Ec-ArsC and it has been postulated that the ArsC-YffB
family of proteins might be able to bind glutathione in the absence of
arsenate (Teplyakov et al., 2004).
3.4. Chemical shift perturbation studies with reduced glutathione
In support of the hypothesis that the ArsC-YffB family of proteins
may bind glutathione in the absence of arsenate ions, it has been
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Figure 7
Superposition of the structure closest to the mean for Bm-YffB (PDB entry 2kok,
blue) on the crystal structure determined for E. coli ArsC (PDB entry 1id9,
magenta; Martin et al., 2001) using the program SuperPose (Maiti et al., 2004). The
side chains of the three arginine residues in Ec-ArsC (Arg60, Arg94 and Arg107)
that form a thiasahydroxyl adduct that is essential for enzymatic function are
labeled and colored red. The only residue in Bm-YffB that is equivalent to those in
the arginine triad of Ec-ArsC is Arg96; this side chain is colored black.
Figure 8
Overlay of the
1H–
15N HSQC spectrum of
15N-labeled Bm-YffB (black) on the
spectrum collected in the presence of a 2:1 molar ratio of glutathione:Bm-YffB
(magenta). Residues that were signiﬁcantly perturbed are labeled. The spectrum at
an  1:1 molar ratio of glutathione:Bm-YffB was similar to that shown here at a 2:1
molar ratio. Data were collected at a proton resonance frequency of 600 MHz at
293 K.
Figure 6
Superposition of the structure closest to the mean for Bm-YffB (PDB entry 2kok,
blue) on the crystal structure determined for Pa-YffB (PDB entry 1rw1, magenta;
Teplyakov et al., 2004) using the program SuperPose (Maiti et al., 2004).shown by mass spectrometry that P. aeruginosa YffB can bind
glutathione (Teplyakov et al., 2004). One of the advantages of
structure determination by NMR-based methods is that following the
chemical shift assignment of the
1H–
15N HSQC spectrum, not only is
it possible to quickly detect ligand binding to the protein by chemical
shift perturbation experiments, but, it is also possible to map the
location of the binding interaction on the three-dimensional structure
of the protein (Buchko et al., 1999; Zuiderweg, 2002). This is possible
because protein–ligand interactions often manifest as changes in the
chemical environment of the nuclei at the interface of ligand binding
which are accompanied by perturbations in the measurable chemical
shifts of the backbone
1H
N and
15N resonances. Upon identifying the
resonances that experience a binding-dependent chemical shift or
intensity perturbation, it is possible to map the location of the binding
site onto the structure of the protein. Fig. 8 is the result of such an
experiment following the titration of reduced glutathione into a
15N-labeled sample of Bm-YffB. At a 2:1 molar ratio of reduced
glutathione:Bm-YffB, a subset of seven resonances are observed to
shift. In Fig. 9 these perturbed resonances are mapped onto the
structure of Bm-YffB and it is observed that they all cluster into one
area (red) adjacent to the potential GX3CX3K catalytic sequence
motif (yellow). The latter observation adds support to the hypothesis
that Bm-YffB and other proteins in the YffB family may function as
glutathione-dependent thiol reductases.
4. Conclusions
The solution structure determined for Bm-YffB is similar to the
crystal structure reported for the YffB protein from P. aeruginosa:a
four-stranded mixed  -sheet ﬂanked by two  -helices on one side and
an  -helical bundle. While the protein sequences of Bm-YffB and
Pa-YffB are marginally similar to the amino-acid sequences of clas-
sical arsenate reductases (ArsC), comparison of the structures of
YffB proteins and ArsC proteins suggest that the substrate speciﬁ-
cities and mechanisms of these two families of proteins may differ.
Chemical shift perturbation studies with reduced glutathione corro-
borate the hypothesis that YffB proteins may function as glutathione-
dependent thiol reductases. Further biochemical and biophysical
studies will be necessary in order to identify the substrate and work
out the details of the mechanism before Bm-YffB may be exploited
for structure-based drug design. The solution structure and bio-
physical data presented here for Bm-YffB will facilitate these efforts.
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